Company / Capital Returned to Shareholders
Haemonetics Capital Returned to Shareholders History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
-
FY2026
5-year range
$0 / $225.0M
FY2022-FY2026
Trend
-
vs FY2025
Sector context
#96 of 108
Health Care
What the data says
Remained stable around $0 over the past 3 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 108
▼
Key checks
Key Insights
- Peak capital returned to shareholders was recorded in FY2024.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $0 | - |
| FY2025 | - | - |
| FY2024 | $225.0M | - |
| FY2023 | $0 | -100.0% |
| FY2022 | $75.0M | - |
| FY2021 | $0 | - |
| FY2020 | $0 | -100.0% |
| FY2019 | $175.0M | +9.4% |
| FY2018 | $160.0M | +60.0% |
| FY2017 | $100.0M | - |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026